Author Details

Nasonov, E L

Issue Section Title File
Vol 78, No 5 (2003) Editorial Use of monoclonal antibodies to tumor necrosis factor (the drug remicade) in rheumatoid arthritis: pilot results
Vol 78, No 5 (2003) Editorial Effects of pulse-therapy on natural anticoagulant system of the endothelium in nonspecific aortoarteritis
Vol 78, No 5 (2003) Editorial Current approaches to prevention and treatment of antiphospholipid syndrome
Vol 78, No 5 (2003) Editorial Adhesion molecules in scleroderma systematica
Vol 79, No 5 (2004) Editorial Rheumatoid arthritis as a general medical problem
Vol 79, No 5 (2004) Editorial The level of TNF soluble receptor type 1 in patients with systemic sclerosis
Vol 79, No 5 (2004) Editorial Blood nitrates content in patients with systemic lupus erythematosus and antiphospholipid syndrome
Vol 79, No 1 (2004) Editorial Medical information-analytical center as an instrument of strategic and everyday planning in health service
Vol 79, No 5 (2004) Editorial Changes in inflammatory activity of rheumatoid arthritis at early stages of basic therapy with leflunomide
Vol 79, No 6 (2004) Editorial Detection of sodium monourate crystals in biopsies of gastric mucosa in gout patients
Vol 79, No 5 (2004) Editorial Immunoresistance syndrome in gout patients and its influence on formation of clinical features of the disease
Vol 79, No 12 (2004) Editorial Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
Vol 80, No 5 (2008) Editorial Early diagnosis of rheumatoid arthritis in modern clinical practice (results of a follow-up of a Moscow cohort of early arthritis patients participating in the program RADICAL)
Vol 80, No 5 (2008) Editorial Soluble CD40 Ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection
Vol 80, No 5 (2008) Editorial Interleukin-18 in systemic lupus erythematosus: link with clinical symptoms and vascular atherosclerosis
Vol 80, No 5 (2008) Editorial Behcet's disease and joint affection
Vol 80, No 8 (2008) Editorial Administration of monoclonal antibodies to b-lymphocytes (rituximab) in rheumatoid arthritis in Russia
Vol 81, No 6 (2009) Editorial Prevalence of mental disorders in SLE patients: correlations with the disease activity and comorbid chronic conditions
Vol 81, No 6 (2009) Editorial Clinical implication of assessment of heart rate variability in patients with psoriatic arthritis
Vol 81, No 5 (2009) Editorial Prophylaxis of cardiovascular diseases in rheumatoid arthritis
Vol 81, No 6 (2009) Editorial Combined treatment of gastric ulcers induced by nonsteroid anti-inflammatory drugs. Results of 4-week population-based controlled trial of efficacy of proton pump inhibitor combination with tripotassium bismuth dicitrate
Vol 81, No 6 (2009) Editorial Rituximab treatment of rheumatoid arthritis: new evidence
Vol 81, No 8 (2009) Editorial Clinical experience with infliximab administration in patients with rheumatoid arthritis by Russian register data
Vol 81, No 10 (2009) Editorial Relationship between the intima-media complex thickness, the risk factors of cardiovascular diseases, and the level of C-reactive protein in gouty patients
Vol 82, No 5 (2010) Editorial Rheumatic diseases: Current technologies and perspectives of laboratory diagnosis
Vol 82, No 5 (2010) Editorial New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)
Vol 82, No 6 (2010) Editorial The first experience in using rituximab in Mikulicz's disease
Vol 83, No 5 (2011) Editorial Perspectives of the treatment of rheumatic diseases in the beginning of the XXI century
Vol 83, No 5 (2011) Editorial Ten-year risk of cardiovascular complications in patients with rheumatoid arthritis
Vol 83, No 5 (2011) Editorial Current knowledge about pathogenesis and treatment of arterial hypertension in rheumatoid arthritis
Vol 84, No 5 (2012) Editorial RHEUMATOID ARTHRITIS: PROBLEMS AND SIGNIFICANCE OF PERSONALIZED MEDICINE
Vol 84, No 5 (2012) Editorial TOCILIZUMAB IMPACT ON BLOOD CHOLESTERINE TRANSPORT AND EARLY MANIFESTATION OF ATHEROSCLEROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
Vol 84, No 5 (2012) Editorial FRAX-ASSISTED PREDICTION OF FRACTURES IN PATIENTS WITH RHEUMATOID ARTHRITIS
Vol 84, No 5 (2012) Editorial HCV-ASSOCIATED CRYOGLOBULINEMIC VASCULITIS
Vol 84, No 5 (2012) Editorial THE LEVELS OF PLASMINOGEN AND INHIBITOR OF PLASMINOGEN ACTIVATORS OF TYPE 1 IN ANTIPHOSPHOLIPID SYNDROME
Vol 84, No 8 (2012) Editorial The efficiency and safety of adalimumab treatment in patients with active rheumatoid arthritis unresponsive to standard therapy: Russian national study results
Vol 84, No 5 (2012) Editorial CURRENT TRENDS IN CLASSIFICATION AND TREATMENT OF SYSTEMIC VASCULITIS ASSOCIATED WITH ANTI-NEUTROPHILIC CYTOPLASMIC ANTIBODIES: RESULTS OF 2011
Vol 84, No 7 (2012) Editorial Differential diagnosis of Wegener's granulomatosis and extranodal NK/T-cell lymphoma, nasal type
Vol 84, No 12 (2012) Editorial Rituximab therapy for systemic manifestations and MALT lymphomas of the parotid gland in Sjögren's disease: Preliminary data
Vol 85, No 2 (2013) Editorial IgG4-related disease: patient group characterization and rituximab therapy
Vol 85, No 1 (2013) Editorial Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome
Vol 85, No 5 (2013) Editorial Rheumatology in Russia in the early 21st century
Vol 85, No 5 (2013) Editorial The magnitude of fatigue and its association with depression, pain, and inflammatory activity in rheumatoid arthritis
Vol 85, No 5 (2013) Editorial Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis
Vol 85, No 5 (2013) Editorial Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab
Vol 85, No 8 (2013) Editorial Pharmacotherapy for rheumatoid arthritis in the early 21st century: Russian and international experience
Vol 85, No 5 (2013) Editorial Diagnosis and problems in therapy of interstitial lung disease associated with rheumatoid arthritis
Vol 86, No 5 (2014) Editorial Systemic autoimmune rheumatic diseases in 2013: Problems of laboratory diagnosis
Vol 86, No 5 (2014) Editorial Association between bone mineral density and erosive and destructive changes in patients with rheumatoid arthritis: Preliminary results
Vol 86, No 5 (2014) Editorial Cardiovascular diseases in patients with rheumatoid arthritis during long-term methotrexate therapy
Vol 86, No 5 (2014) Editorial Bosentan: A considerable increase in the survival of patients with pulmonary hypertension associated with systemic rheumatic diseases
Vol 86, No 5 (2014) Editorial Long-term follow-up of patients with refractory systemic lupus erythematosus during rituximab treatment
Vol 86, No 5 (2014) Editorial Differential diagnosis of rheumatic diseases and blood cancers involving the nasal cavity and accessory sinuses
Vol 87, No 5 (2015) Editorial Rheumatic diseases and multimorbidity
Vol 87, No 5 (2015) Editorial Left and right ventricular diastolic dysfunction in patients with early rheumatoid arthritis before prescribing disease-modifying antirheumatic therapy
Vol 87, No 5 (2015) Editorial Biological agents and fracture risk
Vol 87, No 11 (2015) Editorial Survival in pulmonary arterial hypertension, associated with connective tissue diseases, treated by sildenafil: results of the prospective study
Vol 87, No 12 (2015) Editorial IgG4-related disease and clonal B-cell lymphoid proliferation: Description of two clinical cases and a review of literature
Vol 88, No 5 (2016) Editorial Cardiovascular disease in rheumatic diseases PDF
(Rus)
Vol 88, No 5 (2016) Editorial Relationship between matrix metalloproteinase-3 levels and articular destructive changes in early and extended rheumatoid arthritis PDF
(Rus)
Vol 88, No 5 (2016) Editorial N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs PDF
(Rus)
Vol 88, No 5 (2016) Editorial Current approaches to diagnosing and treating eosinophilic granulomatosis with polyangiitis: The 2015 international guidelines PDF
(Rus)
Vol 88, No 5 (2016) Editorial Interleukin-6 inhibition and cardiovascular disease in patients with rheumatoid arthritis PDF
(Rus)
Vol 88, No 12 (2016) Editorial Prospects for rheumatoid arthritis pharmacotherapy: New opportunities and recommendations PDF
(Rus)
Vol 89, No 5 (2017) Editorial Independent risk factors for severe cardiovascular events in male patients with gout: Results of a 7-year prospective study PDF
(Rus)
Vol 89, No 9 (2017) Editorial Chronic thromboembolic pulmonary hypertension developed in a female patient with lupus erythematosus and secondary antiphospholipid syndrome PDF
(Rus)
Vol 90, No 5 (2018) Editorial Atherosclerosis: perspectives of anti-inflammatory therapy PDF
(Rus)
Vol 90, No 5 (2018) Editorial Results of one-year treat-to-target strategy in early psoriatic arthritis: data of an open-label REMARCA study PDF
(Rus)
Vol 90, No 5 (2018) Editorial Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases PDF
(Rus)
Vol 90, No 5 (2018) Editorial Association of polymorphisms of HLA-DRB1 and TNF-308 G/A with radiographic joint damage in patients with early rheumatoid arthritis with high inflammatory activity, treated according to the principle of “Treat to target” (REMARKA study) PDF
(Rus)
Vol 90, No 5 (2018) Editorial Efficacy and tolerability of abatacept treatment: results of 12 months observation PDF
(Rus)
Vol 91, No 2 (2019) Editorial The use of Tofacitinib in the treatment of inflammatory bowel disease PDF
(Rus)
Vol 91, No 5 (2019) Editorial Rheumatoid arthritis: achievements and unresolved issues PDF
(Rus)
Vol 91, No 5 (2019) Editorial Chronic pain and depression in patients with rheumatoid arthritis: results of five - year follow - up PDF
(Rus)
Vol 91, No 5 (2019) Editorial Effectiveness and safety of selective and non - selective factor Xa inhibitors in antiphospholipid syndrome and systemic lupus erythematosus: anti - Xa - activity range PDF
(Rus)
Vol 91, No 5 (2019) Editorial The role of laboratory biomarkers in monitoring of rituximab biosimilar therapy (Acellbia, “BIOCAD”) in patients with rheumatoid arthritis PDF
(Rus)
Vol 91, No 5 (2019) Editorial The сhanges of bone mineral density on the risk of progression of osteoarthritis of the knee PDF
(Rus)
Vol 91, No 8 (2019) Editorial New directions of pharmacotherapy of immune - inflammatory rheumatic diseases PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies